Back
Open Access

Prospects of target series clinical trials.

Session: 5-year outcomes of target all comers randomised trial & prospects of target series clinical trials
Topic: Interventional Cardiology
Speaker: Associate Professor G. Tarantini (Padova, IT)
sponsored by MicroPort Scientific Corporation
Event: ESC Congress 2022

Congress Presentation

About the speaker

Associate Professor Giuseppe Tarantini

University of Padua, Padova (Italy)
9 presentations
1 follower

7 more presentations in this session

Opening & target AC project introduction.

Speaker: Professor A. Baumbach (London, GB)

Access
Slides
Video
Thumbnail

5-year outcomes of target all comers randomised trial.

Speaker: Doctor A. Lansky (New Haven, US)

Access
Slides
Video
Thumbnail

Group discussion.

Speaker: Professor B. Xu (Beijing, CN) Doctor L. Janssens (Bonheiden, BE) Doctor L. Holmvang (Copenhagen, DK) Doctor T. Johnson (Bristol, GB)

Access
Video
Thumbnail

TARGET AC sub-group analysis on diabetics and ACS patients.

Speaker: Professor N. van Royen (Nijmegen, NL)

Access
Slides
Video
Thumbnail

Group discussion.

Speaker: Professor B. Xu (Beijing, CN) Doctor L. Holmvang (Copenhagen, DK) Doctor L. Janssens (Bonheiden, BE) Doctor T. Johnson (Bristol, GB)

Access
Video
Thumbnail

Access the full session

5-year outcomes of target all comers randomised trial & prospects of target series clinical trials

Speakers: Associate Professor G. Tarantini, Professor A. Baumbach, Doctor A. Lansky, Professor B. Xu, Doctor L. Janssens...
Access
Video
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb